Lifetime Cannabis Use Linked to Larger Brain Volume & Better Cognition in Middle-Aged & Older Adults – New 2025 Study

Lifetime Cannabis Use Linked to Larger Brain Volume & Better Cognition in Middle-Aged & Older Adults – New 2025 Study

Published: December 11, 2025 Author: Anika Guha et al. Journal: Journal of Studies on Alcohol and Drugs DOI: 10.15288/jsad.25-00346 PMID: 41379083

A major new observational study using data from the massive UK Biobank (over 500,000 participants) has just been published, and the headline is striking for anyone following the long-running debate about cannabis and brain health:

Lifetime cannabis use was associated with larger regional brain volume in several key areas — particularly regions rich in cannabinoid (CB1) receptors — and showed no evidence of cognitive impairment in middle-aged and older adults (ages 40–70, mean age ~54.5 years).

In fact, the findings suggest the opposite: cannabis may exert protective effects on brain structure and function in later life, in stark contrast to the well-documented negative impacts seen in adolescent and young adult users.

Key Findings at a Glance

  • Positive association with brain volume: Lifetime cannabis users had significantly larger volumes in CB1-rich regions including:
    • Caudate
    • Putamen
    • Hippocampus
    • Amygdala
  • No negative cognitive effects: No evidence of worse performance on cognitive tests among lifetime users compared to never-users.
  • Lifespan difference emphasized: Authors highlight that cannabis appears to affect brain health differently across the lifespan:
    • Adolescence/young adulthood → often reported negative effects (smaller volumes, cognitive deficits)
    • Middle-age & older adulthood → potential protective or neutral-to-positive effects
  • Possible biological explanation: Researchers propose that endocannabinoid system modulation may reduce inflammation, support immune function, and protect against neurodegeneration in aging brains.
  • Sex differences noted: Some patterns varied by sex, likely due to differences in endocannabinoid system expression — underscoring the need to treat sex as a biological variable in future cannabis-brain research.

Study Design & Population

  • Data source: UK Biobank (very large, population-based cohort with high-quality MRI and cognitive assessments)
  • Sample: Adults aged 40–70 years (mean 54.5), including both lifetime users and never-users
  • Measures: Lifetime cannabis exposure history + regional brain volumes (MRI) + standardized cognitive testing
  • Design: Cross-sectional observational (strong associations, but causation not proven)

Important Caveats from the Paper

The authors are careful:

  • These are associations, not proof of causation.
  • Reverse causation is possible (e.g., people with naturally larger CB1-rich brain regions may be more likely to try cannabis).
  • Residual confounding cannot be fully ruled out.
  • Findings apply specifically to middle-aged and older adults — do not generalize to adolescents or young adults.

Bottom Line for Readers in 2026

This 2025 study adds important nuance to the cannabis-brain conversation.

While decades of research (and public messaging) have focused on potential harms in developing brains, emerging data from large cohorts of older adults are painting a very different picture: lifetime cannabis exposure does not appear to harm — and may even be associated with benefits to — brain structure and cognitive function in midlife and beyond.

These findings are consistent with other recent work showing either neutral or potentially protective effects of cannabis/cannabinoids in aging populations, and they stand in contrast to the well-established risks in younger users.

As always with observational data: more research is needed, particularly longitudinal studies and trials that can better establish causality. But the direction is clear — the relationship between cannabis and brain health looks age-dependent, and blanket statements about “cannabis harms the brain” are increasingly inaccurate when applied to middle-aged and older adults.

For anyone in their 40s, 50s, 60s+ who uses or is considering cannabis (recreationally or medically), this paper offers a data-driven reason for cautious optimism.

Full citation (for reference or sharing): Guha A, et al. Lifetime Cannabis Use Is Associated with Brain Volume and Cognitive Function in Middle-Aged and Older Adults. J Stud Alcohol Drugs. 2025 Dec 11. doi: 10.15288/jsad.25-00346. PMID: 41379083.

(Always consult a healthcare provider for personalized medical advice regarding cannabis use.)

What are your thoughts? Have you noticed any changes in how you or people around you think about cannabis as we age? Drop a comment below.

Leave a Comment

Your email address will not be published. Required fields are marked *


Shopping Cart